Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0000902664-21-004071

Director acquired 1,911,752 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aghazadeh Behzad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-26 Grant or award : show line 1 in the form +1,911,752 $13.08 $24,999,981 2,211,752 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-27 Grant or award : show line 2 in the form Stock option (right to buy) +17,549 17,549 D
Loading xslF345X03/ownership.xml…